Shanghai Yuanqi Biopharma, a subsidiary of Rui'ang Gene, has been granted a national invention patent for a 15‑color full‑spectrum flow cytometry reagent kit and monitoring method to detect minimal residual disease (MRD) in acute B‑cell lymphoblastic leukemia.

2026-07-29

Shanghai Yuanqi Biopharma, a subsidiary of Rui'ang Gene, has been granted a national invention patent for a 15‑color full‑spectrum flow cytometry reagent kit and monitoring method to detect minimal residual disease (MRD) in acute B‑cell lymphoblastic leukemia.